Cure My Disease

Don't miss your cure!

 Log in / Sign up

Choosing dialysis or transplant: does a shared approach lead to better decisions?

NCT ID NCT04976166

Knowledge-focused Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether a shared decision making approach, where doctors and patients weigh options together, helps people with advanced chronic kidney disease choose their treatment. Participants are patients whose kidneys are failing and who may need dialysis or a transplant within a year. The study compares this approach to standard education to see if it leads to more informed choices and better satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Shared decision making education
What this could lead to
If it works, this approach could help kidney failure patients feel more prepared and choose a treatment that fits their lives, potentially avoiding emergency dialysis.
What could go wrong
The trial is large but still early. Education may not change choices or improve satisfaction, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,194 people

The number who actually took part.

Started

Feb 2021

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with chronic kidney disease whose nephrologist predicts initiation of renal replacement therapy within 12 months: 1. Patients with grade 5 of chronic kidney disease \[defined as a creatinine-based estimated glomerular filtration rate (eGFR) \< 15 ml/dL/1.73m2 at least 2 times at intervals of 2 weeks or longer\] 2. Patients with the cystatin C-based eGFR \< 15 ml/dL/1.73m2 at least once if the creatinine-based eGFR does not accurately evaluate the kidney function of patient due to patient characteristics 3. Patients whose nephrologist require renal replacement therapy within 12 months due to the patient's comorbidities even when the eGFR is 15ml/dL/1.73m2 or higher * Patients aged between 19 and 80 years * Patients who understand the study * Patients who have no permanent access device for long-term maintenance dialysis Exclusion Criteria: * Patients who have contraindication to perform peritoneal dialysis due to abdominal surgery * Patients whose life expectancy is less than 6 months due to underlying diseases * Patients who have enrolled in other clinical trials within 3 months or plan to participate in other clinical trials during this clinical trial period * Patients judged by the investigator to be inappropriate for participation in this clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease stage 5 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease stage 5

Contacts and locations

Locations

  • Bundang Seoul National University Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Daejeon Eulji Medical Center

    Daejeon, South Korea

  • Dongguk University Ilsan Hospital

    Goyang, South Korea

  • Ewha Woman's University Seoul Hospital

    Seoul, South Korea

  • Gachon University Gil Medical Center

    Incheon, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, South Korea

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea

  • Kyungpook National University Hospital

    Daegu, South Korea

  • Pusan National University Hospital

    Pusan, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul National University Boramae Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital

    Seoul, South Korea

  • The Catholic University of Korea Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea Seoul St. Mary's Hospital

    Seoul, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

  • Yonsei University Wonju Severance Christian Hospital

    Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.